ELASTATHERAPY
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ELASTATHERAPY Trademark

Serial Number: 98391875

ELASTATHERAPY is a trademark filed by Allergan Pharmaceuticals International Limited on February 5, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Allergan Pharmaceuticals International Limited (5 trademarks)

Clonshaugh Business & Technology Park
DUBLIN 17 D17E400 , IE

Entity Type: 77

Trademark Details

Filing Date

February 5, 2024

Registration Date

Not Registered

Published for Opposition

December 10, 2024

Goods & Services

Pharmaceutical preparations and compositions for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; biochemical and biological substances for medical use, namely, forms of protein and polysaccharide preparations for the treatment of acquired and congenital skin conditions and acquired and congenital skin diseases; drug delivery preparations for medical use, namely, forms of protein and polysaccharide preparations used for the controlled release of pharmaceuticals; medical preparations, namely, medicated skin care preparations

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 14, 2026 EXRA
SOU EXTENSION 2 GRANTED
Feb 4, 2026 EX2G
SOU EXTENSION 2 FILED
Feb 4, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 4, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 5, 2025 EXRA
SOU EXTENSION 1 GRANTED
Aug 4, 2025 EX1G
SOU EXTENSION 1 FILED
Aug 4, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Aug 4, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 4, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 10, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 12, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 11, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 11, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 11, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 29, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 29, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 29, 2024 CNRT
ASSIGNED TO EXAMINER
Aug 29, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 3, 2024 NWOS
NEW APPLICATION ENTERED
Feb 5, 2024 NWAP